Larry Cohen serves as the Director of Financial Operations at Clearlyderm, a pioneering medical dermatology practice that is redefining patient care through innovative treatment solutions. With over 20 years of experience in both public accounting and private industry, Larry brings a wealth of expertise to...
Larry Cohen serves as the Director of Financial Operations at Clearlyderm, a pioneering medical dermatology practice that is redefining patient care through innovative treatment solutions. With over 20 years of experience in both public accounting and private industry, Larry brings a wealth of expertise to his role, focusing on the unique financial challenges faced by rapidly growing healthcare organizations. His hands-on approach is instrumental in implementing robust financial practices that ensure operational efficiency and sustainability in a fast-paced environment.
At Clearlyderm, Larry is currently leading key projects aimed at enhancing financial transparency and accountability. He has successfully overseen the integration of advanced payroll systems and inventory management solutions, which have streamlined operations and improved overall financial performance. His strategic planning initiatives have not only optimized the income statement but also positioned the practice for future growth by aligning financial goals with clinical objectives.
Larry's proficiency in managerial finance and strategic financial planning enables him to provide insightful guidance to the executive team, ensuring that financial decisions are data-driven and aligned with the organization's long-term vision. His commitment to fostering a culture of financial discipline is evident in his collaborative approach, working closely with cross-functional teams to drive performance and support Clearlyderm's mission of delivering exceptional dermatological care. As a forward-thinking financial executive, Larry Cohen continues to play a pivotal role in shaping the financial landscape of the medical dermatology sector, making him an invaluable asset to Clearlyderm's ongoing success.
